Sickle cell anemia and transfusion safety in Bamako, Mali. Seroprevalence of HIV, HBV and HCV infections and alloimmunization belonged to Rh and Kell systems in sickle cell anemia patients;Sécurité transfusionnelle et drépanocytose à Bamako, Mali. Séroprévalence des infections à VIH, VHB, VHC et allo-immunisation anti-Rh et Kell chez les drépanocytaires

Transfusion Clinique et Biologique

Volumn 20, Issue 5-6, 2013, Pages 476-481

  Diarra, A B ^a   Guindo, A ^b   Kouriba, B ^a   Dorie, A ^b   Diabate D T ^a   Diawara, S I ^c   Fane B ^b   Toure B A ^b   Traore A ^a   Gulbis, B ^d   Diallo, D A ^b  

^a Centre National de Transfusion Sanguine   (Mali)

^b Centre de Recherche et Lutte Contre la Drépanocytose   (Mali)

^c UNIVERSITY OF BAMAKO   (Mali)

^d ERASME HOSPITAL   (Belgium)

Author keywords

Mali; Red cell alloimmunization; Sickle cell disease; Viral infection

Indexed keywords

BIOLOGICAL MARKER;

ALLOIMMUNIZATION; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; BLOOD GROUP KELL SYSTEM; BLOOD GROUP RHESUS SYSTEM; BLOOD TRANSFUSION; COOMBS TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE COUNT; ERYTHROCYTE TRANSFUSION; HEPATITIS B; HEPATITIS C; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALI; PATIENT SAFETY; PROSPECTIVE STUDY; SCREENING TEST; SEROCONVERSION; SEROPREVALENCE; SICKLE CELL ANEMIA; VIRUS DETECTION; VIRUS GENOME;

ALLO-IMMUNISATION; DRÉPANOCYTOSE; INFECTION VIRALE; MALI; RED CELL ALLOIMMUNIZATION; SICKLE CELL DISEASE; VIRAL INFECTION;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BLOOD GROUP INCOMPATIBILITY; BLOOD SAFETY; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; COOMBS TEST; ERYTHROCYTE TRANSFUSION; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HIV SEROPREVALENCE; HUMANS; IMMUNIZATION; INFANT; ISOANTIBODIES; KELL BLOOD-GROUP SYSTEM; MALE; MALI; MASS SCREENING; MIDDLE AGED; PROSPECTIVE STUDIES; RH-HR BLOOD-GROUP SYSTEM; SEROEPIDEMIOLOGIC STUDIES; VIREMIA;

EID: 84888438102     PISSN: 12467820     EISSN: 19538022     Source Type: Journal    
DOI: 10.1016/j.tracli.2013.04.111     Document Type: Article

References (20)

1. Diallo D.A. Sickle cell disease in Africa: current situation and strategies for improving the quality and duration of survival. Bull Acad Natl Med 2008, 192:1361-1372.
2. Lefrere J.J., et al. Estimate of the residual risk of transfusion-transmitted human immunodeficiency virus infection in sub-Saharan Africa: a multinational collaborative study. Transfusion 2011, 51:486-492.
3. Noizat-Pirenne F. Immunohematologic characteristics in the Afro-caribbean population. Consequences for transfusion safety. Transfus Clin Biol 2003, 10:185-191.
4. Noizat-Pirenne F., Tournamille C. Relevance of RH variants in transfusion of sickle cell patients. Transfus Clin Biol 2011, 18:527-535.
5. Diallo D.A., Guindo A., Dorie A., Djibo N., Algiman E., Ouane O.D., et al. Human parvovirus B19infection in sickle cell anemia patient in Mali: a case-control study. Arch Pediatr 2011, 18:962-965.
6. Diallo D.A., Baby M., Boiré A., Diallo Y.L. Management of pain of acute sickle cell pain crises by health care providers in Mali. Med Trop (Mars) 2008, 68:502-506.
7. Enquête démographique et de santé noIV (EDS) -Mali 2006.
8. Diarra A., Kouriba B., Baby M., Murphy E., Lefrere J.J. HIV, HCV, HBV and syphilis rate of positive donations among blood donations in Mali: lower rates among volunteer blood donors. Transfus Clin Biol 2009, 16:444-447.
9. Batina A.S., et al. Multiple transfusions for sickle cell disease in the Democratic Republic of Congo: the importance of the hepatitis C virus. Transfus Clin Biol 2010, 17:254-259.
10. Segbena A.Y., et al. Human immunodeficiency virus, hepatitis C virus and hepatitis B viruses in patients with sickle cell disease in Togo. Transfus Clin Biol 2005, 6:423-426.
11. Le Turdot-Chicot, et al. Viral seroprevalence, transfusion and alloimmunization in adults with sickle cell anaemia in Guadeloupe. Transfus Clin Biol 2002, 2:115-120.
12. Neto J.P., Lyra I.M., Reis M.G., Goncalves M.S. The association of infection and clinical severity in sickle cell anaemia patients. Trans R Soc Trop Med Hyg 2011, 105:121-126.
13. Baby M., et al. Fréquence de l'allo-immunisation érythrocytaire chez les malades polytransfusés au CHU du point G, Bamako, Mali. Trans Clin Biol 2011, 17:218-222.
14. Tayou C., et al. Le phénotype érythrocytaire dans le système ABO-Rh chez le donneur et le receveur de produits sanguins dans le milieu hospitalier camerounais: adapter l'offre à la demande. Rev Med Brux 2009, 30:145-216.
15. Natukunda B., et al. Red blood cell allo immunization in sickle cell disease patients in Uganda. Transfusion 2009, 50:20-25.
16. Maléwé K. Allo-immunisation anti-érythrocytaire post-transfusionnelle chez les drépanocytaires majeurs: étude primaire. Thèse, Med Abidjan, UFR des Sciences Médicales 2005: no1249.
17. Mc Pherson M.E., et al. HLA allo immunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease. Pediatr Blood Cancer 2010, 54:552-558.
18. Ameen R., Al Shemmari S., Al-Bashir A. Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion. Transfusion 2009, 49:1649-1654.
19. Mariko M. Rique immunologique des transfusions à l'hÔpital Gabriel Touré de Bamako. Thèse, Pharm. Bamako, 2003no62.
20. Pinto P.C., Braga J.A., Santos A.M. Risk factors for alloimminization in patients with sickle cell anemia. Rev Assoc Med Bras 2011, 57:668-673.